Clinical Trial Update: Effect of IL17 Inhibitor in Comparison With Anti-TNF in Patients With Ankylosing Spondylitis

View source ↗

Summary

This clinical trial update describes a study comparing an interleukin-17 inhibitor with an anti-TNF agent in patients with ankylosing spondylitis; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Anti-TNF agent
• IL-17 inhibitor

Snippet

Sponsor: Sohag University | Conditions: Ankylosing Spondylitis | Status: RECRUITING